American Ginseng Treatment for Multiple Sclerosis Related Fatigue

Completed · Phase 2 · Has a placebo group

Conditions studied: Multiple Sclerosis

In brief

This research project will determine the safety and tolerability of ginseng in subjects with MS and will gather preliminary data on the efficacy of ginseng vs placebo for the treatment of MS fatigue.

Key facts

Study ID

NCT00754832

Run by

Oregon Health and Science University

People needed

56

Starts

2005-09-01

Expected to finish

2011-03-01

Last updated by the study team

2012-01-24

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• MS as diagnosed by the McDonald criteria
• Complaint of fatigue that has been persistent for at least 2 months
• FSS score of 4 or greater;
• Age 18-70.

You may not qualify if…

• Use of ginseng or stimulants in the prior 6 weeks
• Acute treatment with glucocorticoids in the prior 6 weeks
• BDI >31
• Significant MS exacerbation in prior 30 days
• Diabetes
• Uncontrolled hypertension
• Other serious medical disease, pregnancy or breastfeeding
• Breast disease
• Abnormal bleeding or clotting disorder
• Current use of warfarin, albendazole, nifedipine, digoxin, bumetadine, selegiline, isocarboxazid, or phenelzine
• Current use of lasix for poorly controlled hypertension or congestive heart failure
• Current drug or alcohol abuse; inability to complete the self report forms

Where it is running

• Oregon Health & Science University — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.